Hematologic Neoplasms - 25 Studies Found
| Recruiting |
: A Phase 1, Dose Finding Study of CC-90002 in Subjects With Advanced Solid and Hematologic Cancers : Hematologic Neoplasms : 2015-02-13 :
|
| Recruiting |
: Phase I Trial of BAY1251152 for Advanced Blood Cancers : Hematologic Neoplasms : 2016-04-18 : Drug: BAY1251152 Weekly infusion of BAY1251152 in 21-day cycles. |
| Completed |
: Multicenter Study of CPX-351(Cytarabine:Daunorubicin) Liposome Injection in Patients With Advanced Hematologic Cancer. : Hematologic Neoplasms : 2006-10-16 : Drug: CPX-351 (Cytarabine:Daunorubicin) Liposome Injection |
| Completed |
: Biomarker Research for Personalized Medicine : Hematologic Neoplasms : 2011-12-06 |
| Completed |
: A Study of RO5045337 [RG7112] in Patients With Hematologic Neoplasms. : Hematologic Neoplasms : 2008-02-18 : Drug: RO5045337 Multiple ascending doses |
| Terminated |
: A Phase I, Dose-escalation Study of AS703569 Given Orally to Subjects With Haematological Malignancies : Haematological Malignancies : 2010-03-02 :
|
| Active, not recruiting |
: Study to Allow Access to Single Agent Panobinostat for Patients Who Are on s.a. Panobinostat Treatment in a Novartis-sponsored Study and Are Benefiting From the Treatment as Judged by the Investigator : Hematologic Neoplasms : 2013-02-26 : Drug: Panobinostat single agent panobinostat starting with last assigned dose and regimen which patient |
| Active, not recruiting |
: Intra-bone Cord Blood Transplantation in Patients With Haematological Malignancies :
|
| Recruiting |
: Nivolumab for Relapsed or Residual Haematological Malignancies After Allogeneic Stem Cell Transplantation : Haematological Malignancy : 2017-05-07 : Drug: Nivolumab Injection Human monoclonal antibody targeting programmed death-1 (PD-1) cell surface rec |